IGC Pharma presents Tau-PET biomarker study at 2026 Global Tau Conference

IGC Pharma, Inc.

IGC Pharma, Inc.

IGC

0.00
  • IGC Pharma will present new Tau-PET biomarker research at 2026 Global Tau Conference held May 14-15 in Washington, D.C., and online.
  • Study assessed whether an imaging-derived measure of tau spreading patterns can help predict Alzheimer’s disease progression in amyloid-positive APOE4 carriers.
  • Results indicated more focal tau patterns aligned with worse cognitive and clinical outcomes, with faster disease-related worsening over time in a key subgroup.
  • Work supports strategy to use advanced imaging analytics to improve patient stratification and disease monitoring, alongside ongoing Phase 2 CALMA trial of IGC-AD1 for agitation in Alzheimer’s disease.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IGC Pharma Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605150800ACCESSWRNAPR_____1167186) on May 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.